Physical Training in Patients With Relapsing Polychondritis
1 other identifier
interventional
10
1 country
1
Brief Summary
Physical training may improve physical capacity and health parameters in various systemic autoimmune diseases. Therefore, the present study will assess the role of an exercise training program in patients with relapsing polychondritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 10, 2017
CompletedFirst Posted
Study publicly available on registry
March 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2021
CompletedApril 30, 2021
April 1, 2021
4.3 years
March 10, 2017
April 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Cardiopulmonary test
Patients will undertake a maximal graded exercise test on a treadmill, with increments in velocity and grade at every minute until volitional exhaustion. VO2peak will be considered as the average of the final 30 s of the test. Ventilatory threshold (VAT) will be determined when ventilatory equivalent for VO2 (VE/VO2) increased without a concomitant increase in ventilatory equivalent for carbon dioxide (VE/VCO2). Respiratory compensation point (RCP) will be determined when VE/VO2 and VE/VCO2 increased simultaneously.
12 weeks
Secondary Outcomes (4)
Strength muscle tests
12 weeks
Healthy Assessment Questionnaire (HAQ)
12 weeks
Functional muscle tests
12 weeks
Muscle biopsy
12 weeks
Study Arms (2)
Patients
ACTIVE COMPARATORPatients will be submitted to physical training (12-weeks, twice/week)
Control group
ACTIVE COMPARATORHealthy individuals will be submitted to physical training (12-weeks, twice/week)
Interventions
Eligibility Criteria
You may qualify if:
- Fullfill the classification criteria of McADAM et al. (1976)
- Using prednisone ≤ 0.5 mg/kg/day in the last three months
- Sedentary
You may not qualify if:
- Disease relapsing
- Overlapping disease
- Chronic and/or current infections (viral, bacterial or fungal)
- Patients undergoing major surgery within six months before the study
- With commitment to ambulation (joint affection in limbs)
- Smoking
- Diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samuel Katsuyuki Shinjo
São Paulo, 01246903, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel K Shinjo, PhD
University of Sao Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 10, 2017
First Posted
March 27, 2017
Study Start
January 1, 2017
Primary Completion
April 29, 2021
Study Completion
April 29, 2021
Last Updated
April 30, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share